Reversal of fetal ductal constriction after maternal restriction of polyphenol-rich foods: An open clinical trial

Journal of Perinatology

Volumn 32, Issue 8, 2012, Pages 574-579

  Zielinsky, P ^a   Piccoli Jr , A L ^a   Manica, J L L ^a   Nicoloso, L H ^a   Vian, I ^a   Bender, L ^a   Pizzato, P ^a   Pizzato, M ^a   Swarowsky, F ^a   Barbisan, C ^a   Mello, A ^a   Garcia, S C ^a  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

fetal ductal constriction; polyphenol rich foods; prostaglandins; pulmonary hypertension

Indexed keywords

POLYPHENOL; PROSTAGLANDIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOPPLER ECHOGRAPHY; DUCTUS ARTERIOSUS; FEMALE; FETAL DUCTAL CONSTRICTION; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HEMODYNAMIC PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL NUTRITION; MEAN DUCTAL DIASTOLIC VELOCITY; MEAN DUCTAL SYSTOLIC VELOCITY; NUTRITIONAL ASSESSMENT; PREGNANCY OUTCOME; PROSTAGLANDIN SYNTHESIS INHIBITION; PULSATILITY INDEX; RIGHT VENTRICULAR TO LEFT VENTRICULAR DIAMETER RATIO; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD FLOW VELOCITY; CONSTRICTION, PATHOLOGIC; DUCTUS ARTERIOSUS; FEMALE; FETAL HEART; HUMANS; POLYPHENOLS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; QUESTIONNAIRES; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 84864453453     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.153     Document Type: Article

References (45)

1. Luchese S, Manica JL, Zielinsky P. Intrauterine ductus arteriosus constriction: analysis of a historic cohort of 20 cases. Arq Bras Cardiol 2003; 81(4): 405-410, 399-404.
2. Momma K, Konishi T, Hagiwara H. Characteristic morphology of the constricted fetal ductus arteriosus following maternal administration of indomethacin. Pediatr Res 1985; 19(5): 493-500. (Pubitemid 15093306)
3. Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 2006; 40(5): 824-829. (Pubitemid 43764999)
4. Toyoshima K, Takeda A, Imamura S, Nakanishi T, Momma K. Constriction of the ductus arteriosus by selective inhibition of cyclooxygenase-1 and-2 in near-term and preterm fetal rats. Prostaglandins Other Lipid Mediat 2006; 79(1-2): 34-42.
5. Takami T, Momma K, Imamura S. Increased constriction of the ductus arteriosus by dexamethasone, indomethacin, and rofecoxib in fetal rats. Circ J 2005; 69(3): 354-358. (Pubitemid 40410194)
6. Jaillard S, Elbaz F, Bresson-Just S, Riou Y, Houfflin-Debarge V, Rakza T et al. Pulmonary vasodilator effects of norepinephrine during the development of chronic pulmonary hypertension in neonatal lambs. Br J Anaesth 2004; 93(6): 818-824. (Pubitemid 39585613)
7. Larrue B, Jaillard S, Lorthioir M, Roubliova X, Butrous G, Rakza T et al. Pulmonary vascular effects of sildenafil on the development of chronic pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2005; 288(6): L1193-L1200. (Pubitemid 40695446)
8. Zenker M, Klinge J, Krüger C, Singer H, Scharf J. Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. J Perinat Med 1998; 26(3): 231-234. (Pubitemid 28368022)
9. Talati AJ, Salim MA, Korones SB. Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. Am J Perinatol 2000; 17(2): 69-71.
10. Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A et al. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 1996; 97(5): 658-663. (Pubitemid 26138095)
11. Gewillig M, Brown SC, De Catte L, Debeer A, Eyskens B, Cossey V et al. Premature foetal closure of the arterial duct: clinical presentations and outcome. Eur Heart J 2009; 30(12): 1530-1536.
12. Trevett Jr TN, Cotton J. Idiopathic constriction of the fetal ductus arteriosus. Ultrasound Obstet Gynecol 2004; 23(5): 517-519. (Pubitemid 38639534)
13. Soslow JH, Friedberg MK, Silverman NH. Idiopathic premature closure of the ductus arteriosus: an indication for early delivery. Echocardiography 2008; 25(6): 650-652. (Pubitemid 351861999)
14. Zielinsky P, Piccoli Jr AL, Manica JL, Nicoloso LH, Frandlich R, Menezes H et al. Maternal ingestion of herbal tea and grape juice during pregnancy may cause fetal ductal constriction. Circulation 2008; 117: 54.
15. Zielinsky P, Piccoli Jr AL, Manica JL, Nicoloso LH, Menezes H, Busato A et al. Maternal consumption of polyphenol-rich foods in late pregnancy and fetal ductus arteriosus flow dynamics. J Perinatol 2010; 30(1): 17-21.
16. Zielinsky P, Piccoli Jr AL, Manica JL, Nicoloso LH. New insights on fetal ductal constriction: role of maternal ingestion of polyphenol-rich foods. Expert Rev Cardiovasc Ther 2010; 8(2): 291-298.
17. Sridharan S, Archer N, Manning N. Premature constriction of the fetal ductus arteriosus following the maternal consumption of camomile herbal tea. Ultrasound Obstet Gynecol 2009; 34(3): 358-359.
18. Kapadia V, Embers D, Wells E, Lemler M, Rosenfeld CR. Prenatal closure of the ductus arteriosus and maternal ingestion of anthocyanins. J Perinatol 2010; 30(4): 291-294.
19. Zielinsky P, Areias JC, Piccoli Jr AL, Manica JL, Nicoloso LH, Menezes H et al. An experimental study of the role of maternal ingestion of green tea, mate tea and grape juice as cause of fetal ductal constriction. Circulation 2008; 117: 54.
20. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992; 21(3): 334-350.
21. Nag Chaudhuri AK, Karmakar S, Roy D, Pal S, Pal M, Sen T. Anti-inflammatory activity of Indian black tea (Sikkim variety). Pharmacol Res 2005; 51(2): 169-175. (Pubitemid 40040549)
22. Geronikaki AA, Gavalas AM. Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Comb Chem High Throughput Screen 2006; 9(6): 425-442. (Pubitemid 44024700)
23. Aneja R, Odoms K, Denenberg AG, Wong HR. Theaflavin, a black tea extract, is a novel anti-inflammatory compound. Crit Care Med 2004; 32(10): 2097-2103. (Pubitemid 39372545)
24. Sang S, Lambert JD, Tian S, Hong J, Hou Z, Ryu JH et al. Enzymatic synthesis of tea theaflavin derivatives and their anti-inflammatory and cytotoxic activities. Bioorg Med Chem 2004; 12(2): 459-467. (Pubitemid 38064217)
25. Schinella GR, Troiani G, Dávila V, de uschiazzo PM, Tournier HA. Antioxidant effects of an aqueous extract of Ilex paraguariensis. Biochem Biophys Res Commun 2000; 269(2): 357-360. (Pubitemid 30440303)
26. Bixby M, Spieler L, Menini T, Gugliucci A. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci 2005; 77(3): 345-358. (Pubitemid 40703894)
27. Actis-Goretta L, Mackenzie GG, Oteiza PI, Fraga CG. Comparative study on the antioxidant capacity of wines and other plant-derived beverages. Ann N Y Acad Sci 2002; 957: 279-283. (Pubitemid 34721673)
28. de la Lastra CA, Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 2005; 49(5): 405-430. (Pubitemid 40780389)
29. Sun J, Chu YF, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem 2002; 50(25): 7449-7454. (Pubitemid 35424917)
30. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124(3): 453-469. (Pubitemid 16047362)
31. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122(1): 51-65. (Pubitemid 15010435)
32. USDA Database for the Flavonoid Content of Selected Foods. Release 2.1. Web site http://www.ars.usda.gov/nutrientdata,January 2007.
33. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C et al. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 2004; 80(1): 15-21. (Pubitemid 41115549)
34. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81(Suppl 1): 230S-242S.
35. Huhta JC, Moise KJ, Fisher DJ, Sharif DS, Wasserstrum N, Martin C. Detection and quantitation of constriction of the fetal ductus arteriosus by Doppler echocardiography. Circulation 1987; 75(2): 406-412. (Pubitemid 17007348)
36. Mielke G, Benda N. Blood flow velocity waveforms of the fetal pulmonary artery and the ductus arteriosus: reference ranges from 13 weeks to term. Ultrasound Obstet Gynecol 2000; 15(3): 213-218. (Pubitemid 33111839)
37. Momma K, Takeuchi H. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins 1983; 26(4): 631-643. (Pubitemid 14207805)
38. Rudolph AM. The effects of nonsteroidal antiinflammatory compounds on fetal circulation and pulmonary function. Obstet Gynecol 1981; 58(5 Suppl): 63S-67S. (Pubitemid 12163651)
39. Zuckerman H, Shalev E. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol 1985; 153(6): 712-713.
40. Takizawa T, Kihara T, Kamata A, Yamamoto M, Arishima K. Role of nitric oxide in regulating the ductus arteriosus caliber in fetal rats. J Vet Med Sci 2000; 62(7): 707-710.
41. Van Overmeire B, Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005; 10(2): 177-184. (Pubitemid 40215544)
42. Respondek M, Weil SR, Huhta JC. Fetal echocardiography during indomethacin treatment. Ultrasound Obstet Gynecol 1995; 5(2): 86-89.
43. Broussard CS, Louik C, Honein MA, Mitchell AA. Herbal use before and during pregnancy. Am J Obstet Gynecol 2010; 202(5): 443 e1-6.
44. Holst L, Wright D, Haavik S, Nordeng H. The use and the user of herbal remedies during pregnancy. J Altern Complement Med 2009; 15(7): 787-792.
45. Louik C, Gardiner P, Kelley K, Mitchell AA. Use of herbal treatments in pregnancy. Am J Obstet Gynecol 2010; 202(5): 439 e1-439 e10.